GNG5 Protein — G Protein Subunit Gamma 5

GNG5 Protein — G Protein Subunit Gamma 5

Introduction

Gng5 Protein — G Protein Subunit Gamma 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@a2005]
<table> [@href2002]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">G Protein Subunit Gamma 5</th></tr>
<tr><td><strong>Protein Name</strong></td><td>GNG5 (G protein gamma 5)</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/gng5">GNG5</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P63218">P63218</a></td></tr>
<tr><td><strong>Protein Family</strong></td><td>G protein gamma subunit family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~7.8 kDa</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, highest in brain</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/breast-cancer" style="color:#ef9a9a">Breast Cancer</a>, <a href="/wiki/colon-cancer" style="color:#ef9a9a">Colon Cancer</a>, <a href="/wiki/essential-hypertension" style="color:#ef9a9a">Essential Hypertension</a>, <a href="/wiki/hypertriglyceridemia" style="color:#ef9a9a">Hypertriglyceridemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Overview

GNG5 Protein — G Protein Subunit Gamma 5

Introduction

Gng5 Protein — G Protein Subunit Gamma 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@a2005]
<table> [@href2002]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">G Protein Subunit Gamma 5</th></tr>
<tr><td><strong>Protein Name</strong></td><td>GNG5 (G protein gamma 5)</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/gng5">GNG5</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P63218">P63218</a></td></tr>
<tr><td><strong>Protein Family</strong></td><td>G protein gamma subunit family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~7.8 kDa</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, highest in brain</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/breast-cancer" style="color:#ef9a9a">Breast Cancer</a>, <a href="/wiki/colon-cancer" style="color:#ef9a9a">Colon Cancer</a>, <a href="/wiki/essential-hypertension" style="color:#ef9a9a">Essential Hypertension</a>, <a href="/wiki/hypertriglyceridemia" style="color:#ef9a9a">Hypertriglyceridemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Overview

GNG5 (G Protein Subunit Gamma 5) is a member of the heterotrimeric G protein gamma subunit family. G proteins are essential signaling molecules that transmit extracellular signals from G protein-coupled receptors (GPCRs) to intracellular effectors. GNG5 forms heterotrimers with Gα and Gβ subunits, playing critical roles in various cellular signaling cascades.

Structure

The G protein gamma subunit (GNG5) is a small protein of approximately 68 amino acids. It possesses a C-terminal CAAX motif (Cys-Amino-Amino-X) that undergoes prenylation (farnesylation), which is essential for membrane localization and proper G protein function. GNG5 associates with Gβ subunits to form functional Gβγ dimers that can modulate numerous downstream effectors.

Function in Neuronal Signaling

GPCR Signaling Modulation

GNG5-containing Gβγ dimers play crucial roles in modulating neuronal GPCR signaling:

• Neurotransmitter receptors: Gβγ complexes regulate signaling through muscarinic [acetylcholine](/entities/acetylcholine) receptors, dopamine receptors, and serotonin receptors
• Ion channel regulation: Gβγ directly modulates G-protein-gated inwardly rectifying potassium (GIRK) channels, affecting neuronal excitability
• Calcium channel modulation: N-type and P/Q-type voltage-gated calcium channels are regulated by Gβγ, affecting neurotransmitter release

cAMP Signaling

Gβγ complexes containing GNG5 can interact with adenylate cyclase isoforms, particularly ADCY5 and ADCY6, modulating cAMP production in response to GPCR activation. This affects protein kinase A (PKA) signaling and downstream phosphorylation events important for synaptic plasticity.

MAPK/ERK Pathway

Gβγ signaling activates the MAPK/ERK pathway through direct interaction with Ras guanine nucleotide exchange factors. This pathway is critical for neuronal survival, differentiation, and plasticity. Dysregulation of Gβγ-mediated MAPK signaling has been implicated in neurodegenerative processes.

Role in Neurodegeneration

Alzheimer's Disease

GNG5 and Gβγ signaling are implicated in [amyloid-beta](/proteins/amyloid-beta) (Aβ) toxicity:

• Synaptic dysfunction: Gβγ signaling contributes to amyloid-beta-induced synaptic impairment
• Neuronal survival: Modulation of PI3K/Akt signaling by Gβγ affects neuronal viability
• Calcium dysregulation: Gβγ complexes influence calcium homeostasis through channel modulation

Parkinson's Disease

G protein signaling is involved in dopaminergic neuron survival:

• D2 dopamine receptor signaling: Gβγ mediates D2 receptor effects on adenylate cyclase
• Neuroprotection: Gβγ-activated PI3K/Akt pathway can protect against mitochondrial toxins
• GPCR dysfunction: Altered GPCR signaling may contribute to progressive dopaminergic degeneration

Therapeutic Implications

Targeting Gβγ signaling represents a potential therapeutic strategy:

• Small molecule inhibitors: Compounds that disrupt Gβγ-effector interactions
• Selective modulation: Developing agents that specifically target neuronal Gβγ complexes
• Combination therapies: Gβγ modulators may enhance the efficacy of other neuroprotective agents

Clinical Significance

While GNG5 mutations are not a primary cause of neurodegenerative diseases, polymorphisms in G protein genes may modify disease risk and progression. The gamma subunit composition of Gβγ dimers influences downstream signaling specificity, making them potential targets for precision medicine approaches.

Background

The study of Gng5 Protein — G Protein Subunit Gamma 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Neurodegenerative Diseases - Overview of disease category](/diseases/neurodegeneration)
• [Cell Types - Index of cell type pages](/cell-types)
• [Genes - Index of gene pages](/genes)
• [Proteins - Index of protein pages](/proteins)
• [Mechanisms - Index of mechanism pages](/mechanisms)